These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35481969)

  • 1. CmP Signaling Network Leads to Identification of Prognostic Biomarkers for Triple-Negative Breast Cancer in Caucasian Women.
    Abou-Fadel J; Bhalli M; Grajeda B; Zhang J
    Genet Test Mol Biomarkers; 2022 Apr; 26(4):198-219. PubMed ID: 35481969
    [No Abstract]   [Full Text] [Related]  

  • 2. CmP signaling network unveils novel biomarkers for triple negative breast cancer in African American women.
    Abou-Fadel J; Grajeda B; Jiang X; Cailing-De La O AD; Flores E; Padarti A; Bhalli M; Le A; Zhang J
    Cancer Biomark; 2022; 34(4):607-636. PubMed ID: 35431232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCM signaling complex (CSC) couples both classic and non-classic Progesterone receptor signaling.
    Abou-Fadel J; Jiang X; Grajeda B; Padarti A; Ellis CC; Flores E; Cailing-De La O AD; Zhang J
    Cell Commun Signal; 2022 Aug; 20(1):120. PubMed ID: 35971177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers derived from CmP signal network in triple negative breast cancers.
    Sanchez N; Harvey C; Vincent D; Croft J; Zhang J
    Transl Breast Cancer Res; 2023; 4():21. PubMed ID: 38751477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Members of the CmPn as Biomarkers Distinguish Histological and Immune Subtypes of Hepatic Cancers.
    Abou-Fadel J; Reid V; Le A; Croft J; Zhang J
    Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mPR-Specific Actions Influence Maintenance of the Blood-Brain Barrier (BBB).
    Abou-Fadel J; Jiang X; Padarti A; Goswami DG; Smith M; Grajeda B; Bhalli M; Le A; Walker WE; Zhang J
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc's Association with the CmPn/CmP Signaling Network in Breast Cancer Tumorigenesis.
    Renteria M; Belkin O; Aickareth J; Jang D; Hawwar M; Zhang J
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane Progesterone Receptors (mPRs/PAQRs) Are Going beyond Its Initial Definitions.
    Aickareth J; Hawwar M; Sanchez N; Gnanasekaran R; Zhang J
    Membranes (Basel); 2023 Feb; 13(3):. PubMed ID: 36984647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
    Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
    BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.
    Wiese DA; Thaiwong T; Yuzbasiyan-Gurkan V; Kiupel M
    BMC Cancer; 2013 Sep; 13():403. PubMed ID: 24004841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease.
    Kanaan YM; Sampey BP; Beyene D; Esnakula AK; Naab TJ; Ricks-Santi LJ; Dasi S; Day A; Blackman KW; Frederick W; Copeland RL; Gabrielson E; Dewitty RL
    Cancer Genomics Proteomics; 2014; 11(6):279-94. PubMed ID: 25422359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American Women.
    Ogony JW; Radisky DC; Ruddy KJ; Goodison S; Wickland DP; Egan KM; Knutson KL; Asmann YW; Sherman ME
    Cancer Prev Res (Phila); 2020 Nov; 13(11):901-910. PubMed ID: 32753376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.
    Grunda JM; Steg AD; He Q; Steciuk MR; Byan-Parker S; Johnson MR; Grizzle WE
    BMC Res Notes; 2012 May; 5():248. PubMed ID: 22616718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms.
    Yeh SJ; Hsu BJ; Chen BS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.
    Velloso FJ; Campos AR; Sogayar MC; Correa RG
    BMC Genomics; 2019 Feb; 20(1):152. PubMed ID: 30791886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer.
    Uzelac B; Krivokuca A; Brankovic-Magic M; Magic Z; Susnjar S; Milovanovic Z; Supic G
    Pathol Oncol Res; 2020 Oct; 26(4):2723-2731. PubMed ID: 32681437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of p16 and SOX10 coexpression but not androgen receptor expression in triple-negative breast cancers.
    Yoon EC; Wilson P; Zuo T; Pinto M; Cole K; Harigopal M
    Hum Pathol; 2020 Aug; 102():13-22. PubMed ID: 32565323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances of transcriptomics and proteomics in triple-negative breast cancer prognosis assessment.
    Li Y; Kong X; Wang Z; Xuan L
    J Cell Mol Med; 2022 Mar; 26(5):1351-1362. PubMed ID: 35150062
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Uzelac B; Krivokuca A; Susnjar S; Milovanovic Z; Supic G
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):227-235. PubMed ID: 33734898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.